XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the Company’s stock option activity and related information is as follows:
Options Outstanding
Shares
Available for Grant 
Shares Subject to Options OutstandingWeighted-Average Exercise Price Weighted-Average Remaining Contractual Life (Years)Aggregate Intrinsic Value
(unaudited)
(in thousands)
Balance as of January 1, 2025
11,996,2644,631,750$32.98 7.1$35,980 
2018 Plan annual increase(1)
3,689,000
Granted(632,803)632,80343.97 
Exercised(220,541)23.67 
Canceled56,446(56,446)30.93 
Restricted stock units granted
(2,598,915)— 
Restricted stock units canceled
873,684— 
Performance-based restricted stock units granted(281,378)— 
Performance-based restricted stock units adjusted for performance achievement(144,972)— 
Performance-based restricted stock units canceled178,807— 
Balance as of September 30, 2025
13,136,1334,987,566$34.65 6.7$158,068 
Vested and Exercisable as of September 30, 2025
2,823,123$35.01 5.1$96,723 
(1)Effective as of January 1, 2025, an additional 3,689,000 shares of common stock became available for issuance under the 2018 Plan, as a result of the operation of an automatic annual increase provision therein.
Schedule of Restricted Stock Activity
A summary of the Company’s restricted stock unit activity excluding the performance-based restricted stock units and related information is as follows:
Restricted Stock Units OutstandingWeighted-Average Grant Date Fair Value
(unaudited)
Balance as of January 1, 2025
7,020,251$30.11 
Granted2,598,91543.27 
Vested and released(1,187,140)36.67 
Canceled(873,684)31.78 
Balance as of September 30, 2025
7,558,342$33.42 
A summary of the Company’s PSU activity and related information is as follows:
Performance-based Restricted Stock Units OutstandingWeighted-Average Grant Date Fair Value
(unaudited)
Balance as of January 1, 2025
1,290,684$37.07 
Granted281,37847.85 
Vested and released(269,992)69.33 
Adjusted for performance achievement144,97219.29 
Canceled(178,807)63.34 
Balance as of September 30, 2025
1,268,235$26.86 
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following table presents the effect of employee and non-employee related stock-based compensation expense:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(unaudited)
(in thousands)
Cost of revenue
$2,501 $3,894 $7,444 $7,420 
Research and development expense
13,478 18,643 39,788 38,413 
Sales and marketing expense
11,185 13,215 32,458 27,633 
General and administrative expense
15,644 14,017 43,337 30,579 
Total stock-based compensation expense
$42,808 $49,769 $123,027 $104,045 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The grant date fair value of stock options was estimated using a Black-Scholes option-pricing model with the following weighted-average assumptions:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(unaudited)
Expected term (in years)
5.79 - 6.10
5.81 - 6.09
5.50 - 6.10
5.50 - 6.09
Expected volatility
65.4% - 65.8%
68.7% - 69.2%
65.4% - 67.0%
67.8% - 69.4%
Risk-free interest rate
3.7% - 3.9%
3.8% - 4.1%
3.7% - 4.3%
3.8% - 4.5%
Expected dividend yield
—%
—%
—%
—%
The grant date fair value of the stock purchase rights granted under the ESPP for the nine months ended September 30, 2025 and 2024 was estimated using a Black-Scholes option-pricing model with the following assumptions:
Nine Months Ended September 30,
20252024
(unaudited)
Expected term (in years)
0.50
0.50
Expected volatility
69.0%
64.2%
Risk-free interest rate
4.3%
5.4%
Expected dividend yield
—%
—%